Latest Regulatory Framework News

Hanwha Group claims US approval to fully own Austal, but independent checks suggest a narrower green light. Australian regulators still hold the final say on foreign ownership.

Genetic Technologies Limited has signed binding term sheets to acquire Ellerfield Wealth and Walker Capital, marking a strategic shift into wealth management backed by a $7.8 million valuation and pending ASX approvals.

GTI Energy’s updated scoping study for its Lo Herma Uranium Project in Wyoming highlights a promising low-cost in-situ recovery operation with robust economics and a 7-year mine life. The study outlines a central processing plant scenario delivering strong returns amid a supportive regulatory and infrastructure environment.

The Australian Government has delayed the rollout of the new Aged Care Act 2024, postponing key funding reforms from July to November 2025. Regis Healthcare acknowledges the delay and promises ongoing updates.

Gold Mountain Limited has issued nearly 486 million shortfall shares to underwriter Jose Luis Manzano, lifting its recent trading halt. A second tranche to Magnus Capital awaits shareholder approval, marking a pivotal step in the company’s capital raising.

Origin Energy has refined its FY25 earnings forecast, buoyed by strong wholesale performance but tempered by Octopus Energy's UK weather-related losses. Despite setbacks, Octopus continues to expand its retail footprint.

Adriatic Metals has confirmed ongoing discussions with Dundee Precious Metals regarding a possible takeover offer, marking the start of a formal offer period under the UK Takeover Code. While talks continue, no firm offer has yet been made.

First Au Limited’s trading suspension has been lifted following its announcement of a significant gold asset acquisition, signaling renewed market activity for the miner.

Dalrymple Bay Infrastructure Limited reported robust FY-24 results, announcing a 3.6% rise in terminal charges and a 6.5% increase in distribution guidance, underpinned by a $394 million capital investment program.

Infinity Lithium Corporation has withdrawn from Spain’s PERTE VEC IIa capital funding program, opting to return nearly €20 million due to prolonged permitting and regulatory hurdles.

LTR Pharma has expanded patient access to its fast-acting erectile dysfunction treatment SPONTAN by partnering with TerryWhite Chemmart’s extensive pharmacy network, marking a significant step in its commercial rollout and regulatory strategy.

Manhattan Corporation Limited (ASX: MHC) unveils strategic advances across its high-grade gold, lithium, and uranium projects, highlighted by a farm-in joint venture with Novo Resources and key management appointments.